Explore the complexities of malaria vaccine development, targeting Plasmodium species/stages, immunity evidence, and broad vaccine approaches focusing on sub-unit vaccines. Discover the quest for an effective and accessible malaria vaccine.

7 views • 32 slides

This toolkit provides guidance for GP practices in South West England on improving flu vaccination uptake for eligible children and adults. It includes strategies to increase vaccination rates, setting up flu programmes, recalling patients, and maximizing opportunities to co-administer vaccines. The

4 views • 16 slides

Shirebrook, a deprived area in Derbyshire, has been grappling with health inequalities and vaccine hesitancy, particularly among certain groups like ethnic minorities and those living in deprivation. Efforts have been made to engage the community, resulting in varying levels of vaccine uptake among

1 views • 14 slides

This content provides updates on infectious disease prevention efforts, including historical data, TB data posting schedule, and HIV surveillance updates. It also highlights the plans of the US Department of Health and Human Services to produce 4.8 million doses of the H5N1 avian flu vaccine for pan

0 views • 7 slides

Congratulations on your infant reaching 2 months! Learn about the importance of vaccines and how to make informed decisions regarding vaccinating your baby. Access valuable resources from CDC to understand vaccine benefits and risks. Still unsure? Get familiar with vaccine-preventable diseases and h

0 views • 14 slides

Polio, a disabling disease caused by the poliovirus, mainly affects children and can lead to paralysis. Efforts to eradicate polio include the development of vaccines like the Inactivated Polio Vaccine (IPV) and Oral Polio Vaccine (OPV). The poliovirus' choice of host, ease of transmission, and impa

0 views • 15 slides

The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains

0 views • 7 slides

London is prioritizing vaccine uptake and tackling cautiousness by leveraging the expertise of Personalised Care roles and Social Prescribing Link Workers. This event highlights innovative approaches and best practices to engage vulnerable communities, provide support, and address concerns around CO

0 views • 12 slides

This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes

0 views • 33 slides

This review delves into the issue of vaccine hesitancy across prisons, aiming to provide recommendations to address the decline in vaccination rates. Utilizing data from 20 sites with high decline rates and 5 sites with high uptake rates, the analysis examines factors like geography, ethnicity, and

0 views • 13 slides

The update discusses the latest information on Pfizer's COVID-19 vaccine, including details on the new technology, storage requirements, logistics handling, and Emergency Use Authorization (EUA). Pfizer's vaccine, with a 95% efficacy rate, requires storage in ultra-low-temperature freezers or therma

0 views • 28 slides

Dr. Chizoba Wonodi is evaluating the use of co-created messages and trusted messengers to improve COVID-19 vaccine acceptance in Northern Nigeria. Vaccine hesitancy due to conspiracy theories and safety concerns remains a challenge. TM-COVAC study aims to design targeted messages using human-centere

0 views • 8 slides

In the latest VASE+ Release 11.4, several new features have been introduced to enhance vaccine management processes. These include a new vaccine selection field, Pfizer vaccine lot addition for 5-11-year-olds, color coding per vaccine type, customizability options, new columns for vaccine name and s

0 views • 8 slides

The Partnership for Evidence-Based Response to COVID-19 (PERC) in Democratic Republic of the Congo (DRC) collects data to assess the impact of COVID-19 and the effectiveness of public health measures. Findings include insights on disease dynamics, PHSM support, risk perceptions, vaccine beliefs, and

0 views • 23 slides

This content provides valuable information on handling vaccines, including determining vaccine viability, identifying wastage, and understanding expiration dates. It includes scenarios covering vaccine storage, reporting spoiled doses, and managing vial wastage. The answers and explanations offered

0 views • 7 slides

Nimrod Muhumuza, from Afya na Haki Institute, presents a critical analysis of vaccine plant setup in Rwanda and Uganda. The discussion focuses on the potential leadership roles of small economies, private sector involvement, sustainability of vaccine production, and the importance of participation f

0 views • 13 slides

The study explores the impact of Efgartigimod, a Neonatal Fc Receptor blocker, on humoral vaccine responses in patients with autoimmune diseases. It discusses how immunosuppressive therapies used in autoimmune disorders may affect susceptibility to infections and impair vaccine immunogenicity, highl

0 views • 18 slides

The weekly report for Week 47, 2022 in Ireland shows the vaccination uptake percentages for Primary Course Completed (PCC), 1st Booster, 2nd Booster, and 3rd Booster across different age groups. As of Week 47, the vaccination rates vary among age groups, with the highest uptake seen in the 65+ years

0 views • 16 slides

The Illinois Department of Corrections emphasizes the importance of the COVID-19 vaccine, highlighting its effectiveness in preventing severe illness. Individuals are encouraged to make an informed decision about vaccination, ensuring protection for themselves and others. The department assures that

0 views • 52 slides

The Oxford-AstraZeneca vaccine has shown a likely but unproven link to cerebral venous sinus thrombus and other blood clotting issues. Despite this, the benefits of vaccination still outweigh the risks, with only approximately 4 cases per million resulting in death. Communication of the potential be

0 views • 10 slides

In this update, Tennessee reports an increase in COVID-19 vaccine uptake with 52.8% having at least one dose and 46.7% fully immunized. The state ranks 40th in vaccine administration per 100K population. Vaccine hesitancy is addressed, and dates of FDA committee meetings on booster authorizations an

0 views • 15 slides

Fiji faced challenges with low vaccine uptake despite intensified communication efforts. The solution involved establishing a dedicated Social Listening Subgroup to gather feedback from various sources and inform operational strategies. This approach led to improved understanding of community sentim

0 views • 5 slides

This presentation discusses the history of vaccine liability and legal battles in the United States, covering events such as the Cutter Incident, the Swine Flu vaccine campaign, and cases like Berkovitz v. U.S. It explores the challenges, consequences, and legal defenses surrounding vaccine-related

0 views • 25 slides

This study delves into the uptake of new tuberculosis diagnostics in Kenya, revealing challenges such as limited access and staffing issues. It highlights preferential coverage of certain diagnostic methods and identifies barriers to utilization, including health system challenges and low disease su

0 views • 10 slides

Explore the connection between stoichiometric plasticity and trace metal distribution, investigate microbial acquisition systems, analyze modes of metal uptake, and address co-limitations and interactions within organisms. Utilize molecular tools to enhance knowledge on trace element bioavailability

0 views • 5 slides

The weekly report on COVID-19 vaccination uptake in Ireland for Week 33, 2022, ending on August 21st, 2022, highlights the percentage uptake of fully vaccinated individuals, booster doses, and doses for immunocompromised individuals across different age groups. The data is continuously updated as va

0 views • 11 slides

This presentation explores the correlation between fathers' uptake of leave and intentions for continued childbearing in South Korea, comparing findings from other countries. It discusses the impact of paid and unpaid work hours, gender role attitudes, and patterns of fathers' leave uptake in differ

0 views • 18 slides

Measles cases are rising in England, particularly in London, with a concerning low vaccination rate. UKHSA predicts high risk in London and nationwide, urging for intervention to prevent further spread. A national campaign focusing on MMR vaccine uptake is set to launch on 14th July, targeting low u

0 views • 10 slides

This preliminary analysis by Jonathan Ramodike explores factors influencing COVID-19 vaccine uptake among health workers in South Africa. The study aims to understand vaccination rates, determinants, and the impact on hospital admissions. Data from over 6,000 health worker records were analyzed to a

0 views • 13 slides

The cell cycle plays a crucial role in the cellular uptake and dilution of nanoparticles within a cell population. This process involves different phases such as G1, S, G2, and M, each with specific functions related to cell growth, DNA synthesis, protein synthesis, and cell division. Understanding

0 views • 20 slides

The Michigan COVID-19 Survey conducted in March 2021 provides valuable insights on vaccine segments, key findings, and likelihood to get the vaccine among residents aged 16 and older. The survey categorizes individuals into Vaccine Definites, Persuadables, and Nevers, highlighting that 61% are firml

1 views • 10 slides

Exploring the use of data to improve flu vaccination programmes in Scotland, focusing on influenza as a case study. The article discusses methods to close the primary-secondary care loop, flu vaccine uptake success, benefits of vaccination, and insights from primary care data analysis on vaccine eff

0 views • 37 slides

Study in Malawi reveals perceptions on COVID-19, with high awareness but varied beliefs regarding the disease, health services, and vaccine acceptance. Challenges include misconceptions, reluctance to seek medical care, and low vaccine uptake in rural areas. The research aims to investigate the effe

0 views • 19 slides

This job aid explains how Site Admins can add, edit, and manage vaccine inventory lots for clinics. Users can add new vaccine lots, edit existing entries, and associate vaccine lots with specific clinics in the system. The process involves entering lot details, NDC code, expiration, and available do

0 views • 4 slides

The Global Vaccine and Immunization Research Forum 2023, scheduled for March 28-30 at Grand Hyatt, Incheon, Korea, will feature keynote speakers, plenary sessions, workshops, and discussions on various topics related to vaccine research, development, and global health. The agenda includes sessions o

0 views • 9 slides

This presentation, developed by CDC's COVID-19 Response Vaccine Task Force and Homelessness Unit, focuses on COVID-19 vaccination basics, safety, prioritization for individuals experiencing homelessness, and strategies to overcome barriers to vaccination. It highlights the importance of understandin

0 views • 49 slides

This campaign pack provides resources for care home providers in London to increase flu vaccine uptake among staff. It includes key messages, strategies, and tools tailored for engaging with healthcare and social care staff, emphasizing the importance of flu vaccination in light of the COVID-19 pand

0 views • 21 slides

New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi

0 views • 6 slides

The NC COVID-19 Vaccine Plan discussed in the October 9, 2020 Task Force Meeting includes details on vaccine supply, distribution goals, clinical trial timelines, safety, and outreach strategies. Key points cover vaccine development progress, trial protocols, distribution targets, and communication

0 views • 6 slides

Phase 3 data of the BNT162b2 mRNA Covid-19 vaccine, including study design, participant groups, primary endpoints, and key findings regarding safety and efficacy. The vaccine demonstrated efficacy against confirmed Covid-19, with reported local and systemic adverse effects within a specified timefra

0 views • 48 slides